Michelle Keefe - Mar 2, 2022 Form 4 Insider Report for Syneos Health, Inc. (SYNH)

Role
President, Medical Affairs & Commercial Solutions
Signature
/s/ Sara Epstein, Attorney-in-Fact
Stock symbol
SYNH
Transactions as of
Mar 2, 2022
Transactions value $
-$427,087
Form type
4
Date filed
3/4/2022, 04:05 PM
Previous filing
Jan 20, 2022
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Award $0 +7.85K +16.94% $0.00 54.2K Mar 2, 2022 Direct F1, F2
transaction SYNH Class A Common Stock Award $0 +2K +3.69% $0.00 56.2K Mar 2, 2022 Direct F3
transaction SYNH Class A Common Stock Award $0 +2.16K +3.84% $0.00 58.3K Mar 2, 2022 Direct F4
transaction SYNH Class A Common Stock Tax liability -$427K -5.29K -9.07% $80.75 53K Mar 2, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021.
F2 Includes 84 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2022.
F3 Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2022, subject to continued employment.
F4 Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.

Remarks:

President, Medical Affairs & Commercial Solutions